Mood disorders in children and adolescents: Psychopharmacological treatment

Graham J. Emslie, Taryn L. Mayes

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Mood disorders are the leading causes of morbidity and mortality in children and adolescence. As a result, many adolescents are treated with psychopharmacologic agents such as antidepressants and mood stabilizers. To date, research into the safety and efficacy of these medications has lagged behind clinical practice. Several controlled trials of antidepressants in this population have recently been completed or are ongoing, yet few controlled trials of mood stabilizers have been conducted. Although acute efficacy of antidepressants is being addressed, many questions remain about pharmacological treatment of early-onset mood disorders. This article will focus on unmet research needs for the psychopharmacologic treatment of child and adolescent mood disorders.

Original languageEnglish (US)
Pages (from-to)1082-1090
Number of pages9
JournalBiological Psychiatry
Volume49
Issue number12
DOIs
StatePublished - Jun 15 2001

Fingerprint

Mood Disorders
Antidepressive Agents
Child Mortality
Research
Therapeutics
Pharmacology
Morbidity
Safety
Population

Keywords

  • Adolescents
  • Antidepressants
  • Bipolar disorder
  • Children
  • Depression
  • Mood stabilizers

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Mood disorders in children and adolescents : Psychopharmacological treatment. / Emslie, Graham J.; Mayes, Taryn L.

In: Biological Psychiatry, Vol. 49, No. 12, 15.06.2001, p. 1082-1090.

Research output: Contribution to journalArticle

@article{60e0553d65ff459aa78b0c7376a5c866,
title = "Mood disorders in children and adolescents: Psychopharmacological treatment",
abstract = "Mood disorders are the leading causes of morbidity and mortality in children and adolescence. As a result, many adolescents are treated with psychopharmacologic agents such as antidepressants and mood stabilizers. To date, research into the safety and efficacy of these medications has lagged behind clinical practice. Several controlled trials of antidepressants in this population have recently been completed or are ongoing, yet few controlled trials of mood stabilizers have been conducted. Although acute efficacy of antidepressants is being addressed, many questions remain about pharmacological treatment of early-onset mood disorders. This article will focus on unmet research needs for the psychopharmacologic treatment of child and adolescent mood disorders.",
keywords = "Adolescents, Antidepressants, Bipolar disorder, Children, Depression, Mood stabilizers",
author = "Emslie, {Graham J.} and Mayes, {Taryn L.}",
year = "2001",
month = "6",
day = "15",
doi = "10.1016/S0006-3223(01)01149-0",
language = "English (US)",
volume = "49",
pages = "1082--1090",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - Mood disorders in children and adolescents

T2 - Psychopharmacological treatment

AU - Emslie, Graham J.

AU - Mayes, Taryn L.

PY - 2001/6/15

Y1 - 2001/6/15

N2 - Mood disorders are the leading causes of morbidity and mortality in children and adolescence. As a result, many adolescents are treated with psychopharmacologic agents such as antidepressants and mood stabilizers. To date, research into the safety and efficacy of these medications has lagged behind clinical practice. Several controlled trials of antidepressants in this population have recently been completed or are ongoing, yet few controlled trials of mood stabilizers have been conducted. Although acute efficacy of antidepressants is being addressed, many questions remain about pharmacological treatment of early-onset mood disorders. This article will focus on unmet research needs for the psychopharmacologic treatment of child and adolescent mood disorders.

AB - Mood disorders are the leading causes of morbidity and mortality in children and adolescence. As a result, many adolescents are treated with psychopharmacologic agents such as antidepressants and mood stabilizers. To date, research into the safety and efficacy of these medications has lagged behind clinical practice. Several controlled trials of antidepressants in this population have recently been completed or are ongoing, yet few controlled trials of mood stabilizers have been conducted. Although acute efficacy of antidepressants is being addressed, many questions remain about pharmacological treatment of early-onset mood disorders. This article will focus on unmet research needs for the psychopharmacologic treatment of child and adolescent mood disorders.

KW - Adolescents

KW - Antidepressants

KW - Bipolar disorder

KW - Children

KW - Depression

KW - Mood stabilizers

UR - http://www.scopus.com/inward/record.url?scp=0035875567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035875567&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(01)01149-0

DO - 10.1016/S0006-3223(01)01149-0

M3 - Article

C2 - 11430850

AN - SCOPUS:0035875567

VL - 49

SP - 1082

EP - 1090

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 12

ER -